↓ Skip to main content
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
Among the highest-scoring outputs from this source (#15 of 6,102)
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (97th percentile)
So far, Altmetric has seen
2 Reddit threads by 2 users.
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
User RufusSG, in the COVID-19 subreddit,
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
User Waldonville, in the Novel Coronavirus (COVID-19) subreddit,